Cardiovascular risk reduction in diabetes: Underemphasised and overdue. Messages from major trials

14Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diabetes markedly increases the risk of coronary artery disease and death, but is underrecognised as a cardiovascular risk factor, despite the existence of effective treatments. Because patients with diabetes are at high risk for coronary disease, they have more to gain from prevention. There is evidence from clinical trials that select cardiovascular therapies may work better in diabetes, beyond their expected benefit, and may prevent diabetes itself.

Cite

CITATION STYLE

APA

Adler, A. I. (2001). Cardiovascular risk reduction in diabetes: Underemphasised and overdue. Messages from major trials. Clinical Medicine. Royal College of Physicians. https://doi.org/10.7861/clinmedicine.1-6-472

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free